Bottom line
What does MEDX hold?
MEDX held 33 positions as of Jun 30, 2026. Its largest holding is Eli Lilly & Co at 18.46% of the fund, and the top 10 positions add up to 72.4%. By asset type it is 93% stocks, 9% cash & short-term funds.
Updated Aug 26, 2026
MEDX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co LLY | Stocks | 18.46% | $3.5M |
| 2 | US Bank Mmda - Usbgfs 7 | Cash & short-term funds | 9.19% | $1.8M |
| 3 | AbbVie Inc ABBV | Stocks | 8.85% | $1.7M |
| 4 | Novartis AG NVS | Stocks | 6.89% | $1.3M |
| 5 | Johnson & Johnson JNJ | Stocks | 5.59% | $1.1M |
| 6 | Alkermes PLC ALKS | Stocks | 5.53% | $1.1M |
| 7 | AstraZeneca PLC AZN | Stocks | 4.98% | $950.9K |
| 8 | Ionis Pharmaceuticals Inc IONS | Stocks | 4.53% | $864.6K |
| 9 | Bristol-Myers Squibb Co BMY | Stocks | 4.42% | $843.8K |
| 10 | Merck & Co Inc MRK | Stocks | 3.96% | $754.6K |
| 11 | Amgen Inc AMGN | Stocks | 3.91% | $746.7K |
| 12 | Alnylam Pharmaceuticals Inc ALNY | Stocks | 3.42% | $652.6K |
| 13 | Biogen Inc BIIB | Stocks | 3.09% | $589.0K |
| 14 | Pfizer Inc PFE | Stocks | 2.86% | $545.4K |
| 15 | Gsk Plc GSK | Stocks | 2.71% | $516.1K |
| 16 | CRISPR Therapeutics AG CRSP | Stocks | 2.64% | $503.3K |
| 17 | Regeneron Pharmaceuticals Inc REGN | Stocks | 2.06% | $392.8K |
| 18 | Beam Therapeutics Inc BEAM | Stocks | 1.51% | $287.9K |
| 19 | Galectin Therapeutics Inc GALT | Stocks | 1.14% | $217.9K |
| 20 | Intellia Therapeutics Inc NTLA | Stocks | 1.12% | $212.9K |
| 21 | Sandoz Group AG SDZNY | Stocks | 0.80% | $152.0K |
| 22 | Replimune Group Inc REPL | Stocks | 0.73% | $139.3K |
| 23 | Vanda Pharmaceuticals Inc VNDA | Stocks | 0.73% | $138.6K |
| 24 | Haleon PLC HLN | Stocks | 0.60% | $114.8K |
| 25 | Lantern Pharma Inc LTRN | Stocks | 0.55% | $104.9K |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 26, 2026